Clinical trial
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in…
NCT00053807 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00053807 |
|---|---|
| Title | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer |
| Official title | Adjuvant Interleukin-2, Interferon-alpha and 5-Fluorouracil for Patients With High Risk of Relapse After Surgical Treatment for Renal Cell Carcinoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Collaborators | University of Glasgow |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | aldesleukin, recombinant interferon alfa, fluorouracil, adjuvant therapy |
| Enrollment | 96 |
| Start date | Feb 1, 1998 |
| Primary completion | Jan 1, 2004 |
| First posted | Feb 6, 2003 |
| Last update posted | Sep 24, 2012 |
| Countries | Austria, Belgium, Hungary, Israel, Italy, Netherlands, Turkey (Türkiye), United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: